bioresorbable stent, bioabsorbable stent, Absorb BVS, visualizing bioresorbable stents
Absorb, imaging bioresorbable stent, BVS under angiography
Absorb, bioresorbable stent, BVS
imaging the BVS, imaging bioresorbable stents
Absorb, imaging bioresorbable stent, BVS under angiography
Absorb, imaging bioresorbable stent, IVUS, Volcano, coronary lesion
SJM, OCT, Optical coherence tomography, Bioresorbable stent, BVS
Bioresorbable stent on IVUS, BVS on IVUS, imaging bioresorbable stents, Absorb

Some have labeled bioresorbable scaffolds (BRS), also known as bioresorbable stents, as the fourth evolution of interventional cardiology. These novel devices follow the successive evolutions of angioplasty, bare metal stents (BMS) and drug-eluting stents (DES), each of which led to a marked improvement in clinical outcomes for patients suffering from coronary artery disease (CAD). The most exciting aspect of BRS is preliminary data shows the vessel is healing, and histologically looks nearly normal approximately three years after scaffold implantation.

July 21, 2016 — A new paper published in the June issue of Computer cautions that while mobile health (mHealth) is poised for a boom, greater privacy and security measures are needed to realize the full benefits of the technology.

European Symposium on the New Agreed Draft Regulations on Medical Devices

World Cardiac Surgery and Angiology Conference

A novel study has found a simple pre-operative echocardiographic measurement of the amount of torsion of the heart predicted outcomes of mitral valve surgery in some heart failure patients. The study was published in JACC: Basic to Translational Science.

New data from the TITAN II trial confirm the safety and efficacy of the Carillon Mitral Contour System in the treatment of functional (secondary) mitral regurgitation (FMR).

At the end of June, experts from three different medical societies released a new guideline to help optimize lifetime management of patients with transposition of the great arteries, a congenital heart defect, both before and after surgical intervention.

July 19, 2016 — Siemens Healthineers recently introduced an expanded Services portfolio, known as Enterprise Services (ES), to help U.S. customers enhance the patient care experience, improve population health and reduce the per- capita cost of healthcare. The new business line was introduced at the 24th Annual Health Forum/American Hospital Association (AHA) Leadership Summit, July 17-19 in San Diego.

Mitralign Inc. announced last week it has completed subject enrollment in the SCOUT early feasibility study in the United States.

Dictum Health Inc. announced the launch of a post-U.S. Food and Drug Administration (FDA)-approval study of its end-to-end telehealth care-delivery system with University of California Davis Medical Center in Sacramento.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now